118 related articles for article (PubMed ID: 7499501)
1. Pituitary adenylate cyclase-activating polypeptides (PACAP27 and PACAP38) inhibit the mobility of murine thymocytes and splenic lymphocytes: comparison with VIP and implication of cAMP.
Delgado M; De la Fuente M; Martínez C; Gomariz RP
J Neuroimmunol; 1995 Nov; 62(2):137-46. PubMed ID: 7499501
[TBL] [Abstract][Full Text] [Related]
2. Pituitary adenylate cyclase-activating polypeptide (PACAP38) modulates lymphocyte and macrophage functions: stimulation of adherence and opposite effect on mobility.
Garrido E; Delgado M; Martínez C; Gomariz RP; De la Fuente M
Neuropeptides; 1996 Dec; 30(6):583-95. PubMed ID: 9004257
[TBL] [Abstract][Full Text] [Related]
3. Inhibition of mitogen-stimulated proliferation of murine splenocytes by a novel neuropeptide, pituitary adenylate cyclase activating polypeptide: a comparative study with vasoactive intestinal peptide.
Tatsuno I; Gottschall PE; Arimura A
Endocrinology; 1991 Feb; 128(2):728-34. PubMed ID: 1989859
[TBL] [Abstract][Full Text] [Related]
4. Vasoactive intestinal peptide and pituitary adenylate cyclase-activating polypeptides (PACAP27) and PACAP38) protect CD4+CD8+ thymocytes from glucocorticoid-induced apoptosis.
Delgado M; Garrido E; Martinez C; Leceta J; Gomariz RP
Blood; 1996 Jun; 87(12):5152-61. PubMed ID: 8652828
[TBL] [Abstract][Full Text] [Related]
5. Characterization of pituitary adenylate cyclase-activating polypeptide 38 (PACAP38)-, PACAP27-, and vasoactive intestinal peptide-stimulated responses in N1E-115 neuroblastoma cells.
Chik CL; Inukai T; Ogiwara T; Boyd H; Li B; Karpinski E; Ho AK
J Neurochem; 1996 Sep; 67(3):1005-13. PubMed ID: 8752106
[TBL] [Abstract][Full Text] [Related]
6. VPAC2-R mediates the lipolytic effects of pituitary adenylate cyclase-activating polypeptide/vasoactive intestinal polypeptide in primary rat adipocytes.
Akesson L; Ahrén B; Edgren G; Degerman E
Endocrinology; 2005 Feb; 146(2):744-50. PubMed ID: 15514088
[TBL] [Abstract][Full Text] [Related]
7. Vasoactive intestinal peptide and pituitary adenylate cyclase-activating polypeptide-38 inhibit IL-10 production in murine T lymphocytes.
Martinez C; Delgado M; Gomariz RP; Ganea D
J Immunol; 1996 Jun; 156(11):4128-36. PubMed ID: 8666779
[TBL] [Abstract][Full Text] [Related]
8. Receptors for VIP and PACAP in guinea pig cerebral cortex: effects on cyclic AMP synthesis and characterization by 125I-VIP binding.
Zawilska JB; Dejda A; Niewiadomski P; Gozes I; Nowak JZ
J Mol Neurosci; 2005; 25(3):215-24. PubMed ID: 15800375
[TBL] [Abstract][Full Text] [Related]
9. Comparative effect of pituitary adenylate cyclase-activating polypeptide on aldosterone secretion in normal bovine and human tumorous adrenal cells.
Bodart V; Babinski K; Ong H; De Léan A
Endocrinology; 1997 Feb; 138(2):566-73. PubMed ID: 9002987
[TBL] [Abstract][Full Text] [Related]
10. VIP1 and VIP2 receptors but not PVR1 mediate the effect of VIP/PACAP on cytokine production in T lymphocytes.
Jiang X; Wang HY; Yu J; Ganea D
Ann N Y Acad Sci; 1998 Dec; 865():397-407. PubMed ID: 9928038
[TBL] [Abstract][Full Text] [Related]
11. Pituitary adenylate cyclase-activating polypeptide regulation of AtT-20/D16v corticotrope cell proopiomelanocortin expression and secretion.
Braas KM; Brandenburg CA; May V
Endocrinology; 1994 Jan; 134(1):186-95. PubMed ID: 8275932
[TBL] [Abstract][Full Text] [Related]
12. Pituitary adenylate cyclase-activating polypeptide type I receptors mediate cyclic AMP-dependent enhancement of neuronal acetylcholine sensitivity.
Margiotta JF; Pardi D
Mol Pharmacol; 1995 Jul; 48(1):63-71. PubMed ID: 7623776
[TBL] [Abstract][Full Text] [Related]
13. Pituitary adenylate cyclase-activating polypeptide and vasoactive intestinal peptide-stimulated cyclic AMP synthesis in rat cerebral cortical slices: interaction with noradrenaline, adrenaline, and forskolin.
Nowak JZ; Kuba K
J Mol Neurosci; 2002; 18(1-2):47-52. PubMed ID: 11931349
[TBL] [Abstract][Full Text] [Related]
14. Characterization and distribution of binding sites for the hypothalamic peptide, pituitary adenylate cyclase-activating polypeptide.
Gottschall PE; Tatsuno I; Miyata A; Arimura A
Endocrinology; 1990 Jul; 127(1):272-7. PubMed ID: 2361473
[TBL] [Abstract][Full Text] [Related]
15. PACAPs stimulate duodenal bicarbonate secretion at PACAP receptors in the rat.
Takeuchi K; Takehara K; Kato S; Yagi K
Am J Physiol; 1997 Mar; 272(3 Pt 1):G646-53. PubMed ID: 9124587
[TBL] [Abstract][Full Text] [Related]
16. Effects of vasoactive intestinal polypeptide (VIP) and pituitary adenylate cyclase activating polypeptide (PACAP) on the spontaneous release of acetylcholine from the rat hippocampus by brain microdialysis.
Masuo Y; Matsumoto Y; Tokito F; Tsuda M; Fujino M
Brain Res; 1993 May; 611(2):207-15. PubMed ID: 8334515
[TBL] [Abstract][Full Text] [Related]
17. The effect of pituitary adenylate cyclase activating polypeptide (PACAP) on amylase secretion from guinea pig pancreatic acini.
Kitagawa M; Naruse S; Ishiguro H; Hayakawa T; Nokihara K
Biomed Pept Proteins Nucleic Acids; 1995; 1(2):73-6. PubMed ID: 9346857
[TBL] [Abstract][Full Text] [Related]
18. Vasoactive intestinal polypeptide and pituitary adenylate cyclase-activating polypeptides stimulate mitogen-activated protein kinase in the pituitary cell line GH4C1 by a 3',5'-cyclic adenosine monophosphate pathway.
Le Péchon-Vallée C; Magalon K; Rasolonjanahary R; Enjalbert A; Gérard C
Neuroendocrinology; 2000 Jul; 72(1):46-56. PubMed ID: 10940738
[TBL] [Abstract][Full Text] [Related]
19. Effect of vasoactive intestinal peptide and pituitary adenylate cyclase-activating polypeptide on pancreatic, hepatic and duodenal mucosal bicarbonate secretion in the pig.
Glad H; Ainsworth MA; Svendsen P; Fahrenkrug J; Schaffalitzky de Muckadell OB
Digestion; 2003; 67(1-2):56-66. PubMed ID: 12743442
[TBL] [Abstract][Full Text] [Related]
20. Hypophysiotropic action of pituitary adenylate cyclase-activating polypeptide (PACAP) in the goldfish: immunohistochemical demonstration of PACAP in the pituitary, PACAP stimulation of growth hormone release from pituitary cells, and molecular cloning of pituitary type I PACAP receptor.
Wong AO; Leung MY; Shea WL; Tse LY; Chang JP; Chow BK
Endocrinology; 1998 Aug; 139(8):3465-79. PubMed ID: 9681497
[TBL] [Abstract][Full Text] [Related]
[Next] [New Search]
